Liste schubauslösender Medikamente bei Lupus erythematodes
und photosensibilisierender Stoffe

Patientenratgeber von Dorothea Maxin

Startseite 25 Jahre Leben mit Lupus - Freiraum für neues Denken Dorothea Maxin - Acceuil  Dorothea Maxin - Home
Ratgeber  Medikamentenliste  Autoimmunheft  Lexikon  Befundhefte  Buchbesprechungen  Lesungen/Vorträge  Leserzuschriften  Mein Leben Dorothea Maxin - My life
Ziele  Dorothea Maxin - Mes objectifs  Dorothea Maxin - My goals  Bestellung/Impressum  Neuigkeiten

Liste schubauslösender Medikamente
Liste schubauslösender Medikamente bei Lupus erythematodes und photosensibilisierender Stoffe
Nachschlagewerk mit 84 Seiten
12 Euro
24. April 2012
Band 5 aus der Reihe "Lupus"
ISBN 978-3-9814940-6-8
3., völlig überarbeitete und erweitere Auflage von Teilen aus "Mein Lupus erythematodes Tagebuch"


Legende    Inhaltsverzeichnis    Seite 27    Literaturverzeichnis mit Hyperlinks zur Originalliteratur


1 Adams JD. Drug induced lupus erythematosus - a case report. Australas J Dermatol. 1978 Apr;19(1):31-2

2 Abramowitz EW. Generalized erythroderma from bismuth in a patient with a fixed type of lupus erythematosus of the face. Arch Derm Syphilol. 1932;25:1115-8

3 Abramowitz EW. Discussion of Costello M. Lupus erythematosus precipitated by sunlight after sulfanilamide therapy. Arch Derm Syphilol. 1939;39(3):598

4 Adachi A, Horikawa T. Paclitaxel-induced cutaneous lupus erythematosus in patients with serum anti-SSA/Ro antibody. J Dermatol. 2007 Jul;34(7):473-6

5 Adachi A, Nagai H, Horikawa T. Anti-SSA/Ro antibody as a risk factor for fluorouracil-induced drug eruptions showing acral erythema and discoid-lupus-erythematosus-like lesions. Dermatology. 2007;214(1):85-8

6 Agudelo CA, Wise CM, Lyles MF. Pur red cell aplasia in procainamide induced systemic lupus erythematosus. Report and review of the literature. J Rheumatol. 1988 Sep;15(9):1431-2

7 Ahuja GK, Schumacher GA. Drug-induced systemic lupus erythematosus. Primidone as a possible cause. J Am Med Assoc. 1966 Nov 7;198(6):669-71

8 Aja de S. [Anormaler Fall von Lupus erythematodes.] Actas Dermosifilogr. 1925;17:66

9 Alarcon GS, Sams WM, Barton DD, Reveille J. Bullous lupus erythematosus rash worsened by Dapsone. Arthritis Rheum. 1984 Sep;27(9):1071-2

10 Alarcon-Segovia D. Drug-induced systemic lupus erythematosus and related syndromes. Clin Rheum Dis. 1975;1(3):573-82

11 Alarcon-Segovia D, Herskovic T, Dearing WH, Bartholomew LG, Cain JC, Shorter RG. Lupus erythematosus cell phenomenon in patients with chronic ulcerative colitis. Gut. 1965 Feb;6(1):39-47

12 Alarcon-Segovia D, Amigo MC, Reyes PA. Connective tissue disease features after thallium poisoning. J Rheumatol. 1989 Feb;16(2):171-4

13 Alexander S. Lupus erythematosus in two patients after griseofulvin treatment of Trichophyton rubrum infection. Br J Dermatol. 1962;74(2):72-4


14 Allston LL. Lupus-like syndrome from minocycline. Schoch Lett. 1984;34:29

15 Altmeyer P. Dermatologische Differenzialdiagnose. Heidelberg: Springer, 2007

16 Altmeyer P, Bacharach-Buhles M. Enzyklopädie der Dermatologie, Venerologie, Allergologie, Umweltmedizin. Heidelberg: Springer, 2010. [7.10.10]

17 Amankwa K. Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors. Clin Pharmacol Ther. 2004 Mar;75(3):242-7

18 Anderegg U, Haustein U-F. Experimentelle Untersuchungen zur quarzinduzierten Sklerodermie. Dtsch Arztebl. 1998;95(18):C-812-6

19 Ansell HB. Drug Eruption (Diphenylhydantoin and Methylphenylethylhydantoin). AMA Arch Derm. 1955;71(1)132-5

20 Antonen J, Saha H, Hulkkonen J, Lumio J, Pasternack A, Hurme M. Increased in vitro production of interleukin 6 in response to trimethoprim among persons with trimethoprim induced systemic adverse reactions. J Rheumatol. 1999 Dec;26(12):2585-90

21 Appel B. Lupus erythematosus on tattoo. Arch Derm Syphilol. 1930;21(5):855-6


22 Arai H, Ito A, Hashimoto A, Eto H, Nishiyama S. Normolipemic xanthoma developed on alopecia lesion on a SLE patient - histological study. Nippon Hifuka Gakkai Zasshi. 1991 Mar;101(4):427-37

23 Aran. Du lupus érythémateux et de son traitement. Union médicale. 1851 Jun 19;5(72) 290-1

24 Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Leitlinie Kutaner Lupus erythematodes. AWMF-Leitlinien-Register Nr. 013/060. [1.8.09]

25 Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Leitlinie Phototoxische und photoallergische Reaktionen. AWMF-Leitlinien-Register Nr. 013/035. [22.10.09]

26 Arrue I, Saiz A, Ortiz-Romero PL, Rodriguez-Peralto JL. Lupus-like reaction to interferon at the injection site: report oft five cases. J Cutan Pathol. 2007 Dec;34 Suppl 1:18-21

27 arznei-telegramm. Netzwerk-UAW-Datenbank. [24.1.12]

28 Assem ES, Banks RA. Practolol-induced drug eruption. Proc R Soc Med. 1973 Feb;66(2):179-81

29 Ayvazian LF, Badger TL. Disseminated lupus erythematosus occurring among student nurses. N Engl J Med. 1948 Oct 14;239(16):565-70

30 Back O, Lundgren R, Wiman LG. Letter: Nitrofurantoin-induced pulmonary fibrosis and lupus syndrome. Lancet. 1974 May 11;1(7863):930

31 Baer RL, Levine BB. Adverse cutaneous reactions to drugs. Fitzpatrick TB, ed. Dermatology in general Medicine. New York: McGraw-Hill, 1971:1281-1314

32 Balabanova MB, Botev IN, Michailova JI. Subacute cutaneous lupus erythematosus induced by radiation therapy. Br J Dermatol. 1997 Oct;137(4):648-9

33 Ball NJ, Cowan BJ, Moore GR, Hashimoto SA. Lobular panniculitis at the site of glatiramer acetate injections for the treatment of relapsing-remitting multiple sclerosis. A report of two cases. J Cutan Pathol. 2008 Apr;35(4):407-10

34 Ballas ZK, Donta ST. Sulindac-induced aseptic meningitis. Arch Intern Med. 1982 Jan 1;142(1):165-6

35 Balsa A, Bernad M, de Miguel E, Crespo M. Subacute cutaneous lupus erythematosus caused by chrysotherapy in rheumatoid arthritis. Rev Clin Esp. 1988 May;182(9):505-6

36 Bannwarth B, Miremont G, Papapietro PM. Lupuslike syndrome associated with simvastatin. Arch Intern Med. 1992 May;152(5):1093

37 Baran LR. Lupus Erythematosus-like Reaction due to Ethionamid. Bull Soc Fr Dermatol Syph. 1966;72:509

38 Barber HW. Lupus erythematosus. Proc R Soc Med (Dermatol Sect). 1915;8:263-5

39 Barber HW. A Case of Lupus Erythematosus Associated with Streptococcal Infection of the Tonsils. Br J Dermatol. 1919;31(4):186-193

40 Barber HW. The effect of sulphonamide compounds upon lupus erythematosus. Br J Dermatol. 1941;53(1):1-18

41 Barbot F, Danan-Causanski S, Chaouat D, Thuong M. Aseptic meningitis after ranitidine treatment for systemic lupus erythematosus. Presse Med. 1999 Nov 13;28(35):1938

42 Bark KM, Heo EP, Han KD, Kim MB, Lee ST, Gil EM, Kim TH. Evaluation of the phototoxic potential of plants used in oriental medicine. J Ethnopharmacol. 2010 Jan 8;127(1):11-8

43 Barnett JH. Discoid Lupus Erythematosus Exacerbated by Contact Dermatitis. Cutis. 1990;46(5):430-2

44 Bauer-Jokl M. Zur Ätiologie des generalisierten Lupus erythematodes. Arch Dermatol Syph. 1919;127(2):342-58

45 Bazex A, Dupre A. [Eruption of the type of lupus erythematosus precipitated by PAS perfusions.] Eruption à type de lupus érythémateux déclenché par des perfusions de P. A. S. Arch Belg Dermatol Syphiligr. 1959 Sep;15:342-3

46 Bechet PE. Lupus erythematosus disseminatus, with extension of the disease after exposure to actinic light. Arch Derm Syphilol. 1926;13(5):701

47 Bechet PE. Acute disseminate lupus erythematosus following sunburn. Arch Derm Syphilol. 1932;26(3):538

48 Bechet PE. Discussion of Costello M. Lupus erythematosus precipitated by sunlight after sulfanilamide therapy. Arch Derm Syphilol. 1939;39(3):598-9

49 Beelar VP. Rheumatoid-arthritis-like syndrome during apresoline therapy: report of a case. Med Ann Dist Columbia. 1953 Dec 22;(12):651-2

50 Beickert A, Heinecke H. Erythema nodosum mit positivem LE-Phänomen und Erythrocytenantikörpern nach Perchlorattherapie. Schweiz Med Wochenschr. 1968;98:2025-8

51 Beickert A. Das Lupus erythematodes-Phänomen und die antinukleären Faktoren. Jena: G. Fischer, 1974

52 Ben-Chetrit A, Ben-Chetrit E. Systemic lupus erythematosus induced by ovulation induction treatment. Arthritis Rheum. 1994 Nov;37(11):1614-7

53 Bensaid J, Aldigier JC, Gualde N. Systemic lupus erythematosus syndrome induced by pindolol. Br Med J. 1979 Jun 16;(6178):1603-4

54 Bentley DD, Graves JE, Smith DI, Heffernan MP. Efalizumab-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol. 2006 May;54(5 Suppl):S242-3

55 Benucci M, Li Gobbi F, Fossi F, Manfredi M, Del Rosso A. Drug-induced lupus after treatment with infliximab in rheumatoid arthritis. J Clin Rheumatol. 2005 Feb;11(1):47-9

56 Bergoend H, Löffler A, Amar R, Maleville J. [Cutaneous reactions appearing during the mass prophylaxis of cerebrospinal meningitis with a long-delayed action sulfonamide (apropos of 997 cases)]. Réactions cutanées survenues au cours de la prophylaxie de masse de la méningite cérébrospinale par un sulfamide long-retard (a propos de 997 cas). Ann Dermatol Syphiligr. 1968;95(5- 6):481-90

57 Berning SE, Cook JL, Iseman MD. Drug-induced lupus syndrome associated with rifamycin therapy (abstract no 156). Clin Infect Dis 1995;21(3):746

58 Bernstein C, Klotz SD. Allergenicity of tranquilizing drugs. J Am Med Assoc. 1957 Mar 16;163(11):930-3

59 Bernstein ET. Lupus erythematosus following laceration by broken glass. AMA Arch Derm. 1951;63(2):261-3

60 Bird MR, O'Neill AI, Buchanan RR, Ibrahim KM, Des Parkin J. Lupus anticoagulant in the elderly may be associated with both quinine and quinidine usage. Pathology. 1995 Apr;27(2):136-9>

61 Bjellerup M, Bruze M, Forsgren A, Krook G, Ljunggren B. Antinuclear antibodies during Puva therapy. Acta Derm Venereol. 1979;59(1):73-5

62 Blazes DL, Martin GJ. Drug-induced lupus erythematosus secondary to nafcillin: the first reported case. Rheumatol Int. 2004 Jul;24(4):242-3

63 Bleck TP, Smith MC. Possible induction of systemic lupus erythematosus by valproate. Epilepsia. 1990;31(3):343-5

64 Bleumink GS, ter Borg EJ, Ramselaar CG, Stricker BHC. Etanercept-induced subacute cutaneous lupus erythematosus. Rheumatology (Oxford). 2001 Nov;40(11):1317-9

65 Blum HF. Photodynamic Action and Diseases Caused by Light. New York: Reinhold Publishing Corporation, 1941

66 Boardman WP. Lupus erythematosus? Arch Derm Syphilol. 1931;23(6):1190

67 Boardman PL, Robinson KC, Dudley Hart F. Guanoxan and Systemic Lupus Erythematosus. Br Med J. 1967 Jan 14;1(5532):111

68 Bode CW. Phototoxikologie der Kaliumkanal-Blocker Psora-3 und Psora-4: In vitro-Untersuchungen zur Photoirritation, Photokarzinogenität und Photoallergenität. Kiel, 2004

69 Bodokh I, Lacour JP, Costa I, Botcazou V, Chichmanian RM, Ortonne JP. Aseptic meningitis during pyrazinamide therapy for lupus erythematosus. Presse Med. 1993 Apr 3;22(12):595-6

70 Bockle BC, Baltaci M, Weyrer W, Sepp NT. Bortezomib-induced lupus erythematosus tumidus. Oncologist. 2009 Jun;14(6):637-9

71 Bonnet F, Morlat P, De Witte S, Combe C, Beylot J. Lupus-like syndrome and vasculitis induced by valpromide. J Rheumatol. 2003 Jan;30(1):208-9

72 Bonsmann G, Schiller M, Luger TA, Ständer S. Terbinafine-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol. 2001;44(6):925-31

73 Boralevi F, Léauté-Labrèze C, Roul S, Couprie B, Taïeb A. Lupus-erythematosus-like eruption induced by Trichophyton mentagrophytes infection. Dermatology. 2003;206(4):303-6

74 Bork K. Arzneimittelnebenwirkungen an der Haut. Stuttgart: Schattauer, 1999

75 Braun. Über die Beziehungen des Syndroms nach Senear-Usher zur Toxikodermie. Dtsch Gesundheitsw. 1951;6(24):692

76 Brenner W, Gschnait F. [Cinnarizin - an up to now unrecognized inducer of a lupus erythematosus-like syndrome.] Cinnarizin - ein bisher unbekannter Induktor eines Lupus-erythematodes-ähnlichen Syndroms. Hautarzt. 1978 Jul;29(7):392-4

77 Brion PH, Mittal-Henkle A, Kalunian KC. Autoimmune skin rashes associated with etanercept for rheumatoid arthritis. Ann Intern Med. 1999;131(8):634

78 Broers JH. Lupus erythematosus acutus. Zbl Hautkrh. 1925;16:76

79 Brogan BL, Olsen, NJ. Drug-Induced Rheumatic Syndromes. Curr Opin Rheumatol. 2003 Jan;15(1):76-80

80 Brooke R, Coulson IH, al-Dawoud A. Terbinafine-induced subacute cutaneous lupus erythematosus. Br J Dermatol. 1998 Dec;139(6):1132-3

81 Brown AC. Lupus erythematodes and nutrition: a review of the literature. J Ren Nutr 2000 Oct;10(4):170-83

82 Bruhns C. Ein Fall von hochgradiger Idiosynkrasie gegen Krysolgan. Letaler Ausgang nach einer Dosis von 0,001 g. Dermatol Wochenschr. 1924;79:945

83 Bruinsma W. A guide to drug eruptions. Oosthuizen: The File of Medicine, 1990

84 Burns DA, Sarkany I. Penicillamine induced discoid lupus erythematosus. Clin Exp Dermatol. 1979;4(3):389-92

85 Burry JN. Lipstick and Lupus Erythematosus. N Engl J Med. 1969;281(11):620-1

86 Callaghan JT, Goldberg MR, Brunelle R. Double-blind comparator trials with pinacidil, a potassium channel opener. Drugs. 1988;36 Suppl 7:77-82

87 Cameron DC. Diffuse pulmonary disorder caused by oxyphenbutazone. Br Med J. 1975 May 31;2(5969):500-1

88 Carter JD, Valeriano-Marcet J, Kanik KS, Vasey FB. Antinuclear antibody-negative, drug-induced lupus caused by lisinopril. South Med J. 2001 Nov;94(11):1122-3

89 Cazenave PLA. Du Lupus. Leçons cliniques sur les maladies de la peau. Paris: Plon, 1855:9-18

90 Cazenave PLA, Schedel HE. Abrégé pratique des maladies de la peau, d'après les auteurs les plus estimés, et surtout d'après des documens puisés dans les leçons cliniques de M. le Docteur Biett, Médecin de l'Hôpital Saint-Louis. Paris: Béchet Jeune, 1833

91 Chapman JA. An unusual nitrofurantoin-induced drug reaction. Ann Allergy. 1986 Jan;56(1):16-8

92 Charniot JC, Genereau T, Mouthon L. Celiprolol-induced lupus-like syndrome. Acta Cardiol. 2006 Dec;61(6):661-3

93 Chen K, Preuss A, Hackbarth S, Wacker M, Langer K, Roder B. Novel photosensitizer-protein nanoparticles for photodynamic therapie: photophysical characterization and in vitro investigations. J Photochem Photobiol B. 2009 Jul 17;96(1):66-74

94 Cluxton HE, Krause LAM. Acute lupus erythematosus disseminatus. Ann Intern Med. 1943;19(6):843-72

95 Codding C, Targoff IN, McCarty GA. Aseptic meningitis in association with diclofenac treatment in a patient with systemic lupus erythematosus. Arthritis Rheum. 1991 Oct;34(10):1340-1

96 Cohen P, Gardner FH. Sulfonamide reactions in systemic lupus erythematosus. J Am Med Assoc. 1966 Sep 5;197(10):817-9

97 Collins D. Pancytopenia, rash and fever caused by diethylstilbestrol used for prostate cancer. J Rheumatol. 1989 Mar;16(3):408-9


98 Colon-Soto M, Peredo RA, Vila LM. Systemic lupus erythematosus after mesotherapy with acetyl-L-carnitine. J Clin Rheumatol. 2006;12(5):261-2

99 Conrad K, Mehlhorn J, Luthke K, Dorner T, Frank KH. Systemic lupus erythematosus after heavy exposure to quartz dust in uranium mines: clinical and serological characteristics. Lupus. 1996 Feb;5(1):62-9

100 Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS. Smoking and use of hair treatments in relation to risk of developing systemic lupus erythematosus. J Rheumatol. 2001 Dec;28(12):2653-6

101 Correia O, Lomba Viana H, Azevedo R, Delgado L, Polonia J. Possible phototoxicity with subsequent progression to discoid lupus following pantoprazole administration. Clin Exp Dermatol. 2001 Jul;26(5):455-6

102 Costello M. Lupus erythematosus precipitated by sunlight after sulfanilamide therapy. Arch Derm Syphilol. 1939;39(3):598-9

103 Couto M, Duarte C, Geraldes A, Medeiros C, Ines L, Malcata A. Rash, fever and proteinuria after amoxicillin in a SLE patient. Acta Reumatol Port. 2009 Jul-Sep;34(3):526-30

104 Cranston Low R, Rutherford A. Post-Mortem Report of a Case of Lupus Erythematosus. Br J Dermatol. 1920;32(11):326-30

105 Crawford GM, Leeper RW. Diseases of the skin during pregnancy. Arch Derm Syphilol. 1950;61(5):753-771

106 Creel N, Werth V. Rhabdomyolysis associated with quinacrine therapy in a patient with chronic cutaneous lupus erythematosus. J Drugs Dermatol. 2005 Mar-Apr;4(2):225-7

107 Crowson AN, Magro CM. Diltiazem and subacute cutaneous lupus erythematosus-like-lesions. N Engl J Med. 1995 Nov 23;333(21):1429

108 Crowson AN, Magro CM. Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy. Hum Pathol. 1997 Jan;28(1):67-73

109 Crowson AN, Magro CM. Lichenoid and subacute cutanous lupus erythematosus-like dermatitis associated with antihistamine therapy. J Cutan Pathol. 1999 Feb;26(2):95-9

110 Curd JG, Milgrom H, Stevenson DD, Mathison DA, Vaughan JH. Potassium iodide sensitivity in four patients with hypocomplementemic vasculitis. Ann Intern Med. 1979 Dec;91(6):853-7

111 D'Arcy V, Laher M, McCoy D, Sullivan P, Walsh CH, Hickey MP. Pinacidil, a new vasodilator, in the treatment of mild to moderate essential hypertension. Eur J Clin Pharmacol. 1985 May;28(3):347-9

112 Dasanu CA, Alexandrescu DT. Systemic lupus erythematosus associated with paclitaxel use in the treatment of ovarian cancer. South Med J. 2008 Nov;101(11):1161-2

Daunderer M. Klinische Toxikologie, 1993

114 Davidson BL, Gilliam JN, Lipsky PE. Cimetidine-associated exacerbation of cutaneous lupus erythematosus. Arch Intern Med. 1982 Jan;142(1):166-7

115 Davies MG. A large outbreak of bitumen-induced phototoxicity in a dockyard. Contact Dermatitis. 1996 Sep;35(3):188-9

116 Delorme P, Giroux JM. Solar urticaria as the presenting manifestation of systemic lupus erythematosus. Can Med Assoc J. 1966 Sep 3;95(10):539-42

117 Descotes J. An Introduction to Immunotoxicology. London: Taylor & Francis, 1999

118 Desmons MF. Aspect pseudolupique provoqué par l'éthionamide (Trecator) chez l'enfant. Bull Soc Fr Dermatol Syph. 1973;80:169-72

119 Deutsche Rheuma-Liga Bundesverband e. V., ed. Der systemische Lupus erythematodes. Ein nützlicher Ratgeber. Bonn, ohne Datumsangabe. Kostenlos erhältlich bei der Rheuma-Liga Hessen e. V., Elektronstr. 12a, 65933 Frankfurt/Main, Tel: 069/357414, rheuma-liga.hessen@t-online.de, oder den anderen Landesverbänden der Rheuma-Liga

120 Deutsches Institut für Medizinische Dokumentation und Information (DIMDI). Anatomisch-therapeutisch-chemische Klassifikation mit Tagesdosen. Amtliche Fassung des ATC-Index mit DDD-Angaben für Deutschland im Jahre 2011.

121 Di Lernia V, Bisighini G. Discoid lupus erythematosus during treatment with cyclosporine. Acta Derm Venereol. 1996 Jan;76(1):87-8

122 Dittrich O. [Erythematodes exacerbated by old salvarsan and cured by uliron.] Erythematodes durch Altsalvarsan exacerbiert, mit Uliron geheilt. Z Haut Geschlechtskr. 1950 Jun 15;8(12):478-9

123 Djawari D. [Drug-induced lupus erythematosus.] Zur Problematik des medikamentös induzierten Lupus erythematodes. Z Hautkr. 1978 Mar 15;53(6):180-8

124 Domke HF, Ludwigsen E, Thormann J. Discoid lupus erythematosus possibly due to photochemotherapy. Arch Dermatol. 1979 May;115(5):642

125 Domz CA, McNamara DH, Holzapfel HF. Tetracycline provocation in lupus erythematosus. Ann Intern Med. 1959 May;50(5):1217-26

126 Dorfmann H, Kahn MF, de Seze S. [Possible iatrogenic lupus induced by phenturide (apropos of 2 cases).] Ann Med Interne (Paris). 1972 Apr;123(4):331-6

127 Drug-induced extrapyramidal symptoms. J Am Med Assoc. 1973 May 7;224(6):889-91

128 Drugs.com. Amitriptyline, Bumetanide, Etacrynic acid. [8.1.10]

129 Duarte C, Ines L. Oral contraceptives and systemic lupus erythematosus: what should we advise to our patients? Acta Reumatol Port. 2010 Apr-Jun;35(2):133-40

130 Dubois EL. Acquired hemolytic anemia as the presenting syndrome of lupus erythematosus disseminatus. Am J Med. 1952 Feb;12(2):197-204

131 Dubois EL. Current therapy of systemic lupus erythematosus. J Am Med Assoc. 1960 Aug 13;173(15):1633-40

132 Dudley K, Micetich K, Massa MC. Erythema with features of seborrheic dermatitis and lupus erythematosus associated with systemic 5-fluorouracil. Cutis. 1987 Jan;39(1):64-6

133 Durox H, Sparsa A, Loustaud-Ratti V, Prey S, Gondran G, Manea P, Vidal E, Bedane C. Efalizumabinduced lupus-like syndrome. Acta Derm Venereol. 2008;88(3):270-1

134 Echaniz-Laguna A, Thiriaux A, Ruolt-Olivesi I, Marescaux C, Hirsch E. Lupus anticoagulant induced by the combination of valproate and lamotrigine. Epilepsia. 1999 Nov;40(11):1661-3

135 Eeckhout E, Willemsen M, Deconinck A, Somers G. Granulomatous vasculitis as a complication of potassium iodide treatment for Sweet's syndrome. Acta Derm Venereol. 1987;67(4):362-4

136 Elias PM. Erythema nodosum and serological lupus erythematosus. Simultaneous occurrence in a patient using oral contraceptives. Arch Dermatol. 1973 Nov;108(5):716-8

137 Ellis FA, Bereston ES. Lupus erythematosus associated with pregnancy and menopause. AMA Arch Derm Syphilol. 1952;65(2):170-6

138 el-Mallakh RS, Donaldson JO, Kranzler HR, Racy A. Phenothiazine-associated lupus anticoagulant and thrombotic disease. Psychosomatics. 1988 Winter;29(1):109-13

139 Engelhart JJ. Drug-induced lupus erythematosus profundus (Kaposi-Irgang). Br J Dermatol. 1982;106(5):607-8

140 Englander M, Davie JM. Antiphospholipid antibodies, cocaine use, and stroke in a young woman. J Clin Rheumatol. 1997 Aug;3(4):224-6

141 Eyanson S, Greist MC, Brandt KD, Skinner B. Systemic lupus erythematosus: association with psoralen-ultraviolet-A-treatment of psoriasis. Arch Dermatol. 1979 Jan;115(1):54-6

142 Fahrner L, Duvic M. Lupus panniculitis. Arch Dermatol. 1986 Jun;122(6):625-6

143 Fakri E, Francois B. [Can lupus be caused by dihydralazine?] Un lupus peut-il être induit par la dihydralazine? Nouv Presse Med. 1979 Nov 19;8(45):3754

144 Farid N, Anderson J. S.L.E.-like reaction after phenylbutazone. Lancet. 1971 May 15;1(7707):1022-3

145 Federmann M, Morell B, Graetz G, Wyss M, Elsner P, von Tiessen R, Wuthrich B, Grob D. Hypersensitivity to molybdenum as a possible trigger of ANA-negative systemic lupus erythematosus. Ann Rheum Dis. 1994 Jun;53(6):403-5

146 Feltkamp TE, Mees EJ, Nieuwenhuis MG. Autoantibodies related to treatment with chlorthalidone and alpha-methyldopa. Acta Med Scand. 1970 Mar 3;187(3):219-23

147 Fernandes NF, Rosenbach M, Elenitsas R, Kist JM. Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy. Arch Dermatol. 2009 Mar;145(3):340-1

148 Feurle GE. [Doxazosin-induced lupus erythematodes.] Doxazosin-induzierter Lupus erythematodes. Dtsch Med Wochenschr. 1992;117(4):157

149 Finkel TH, Hunter DJ, Paisley JE, Finkel RS, Larsen GL. Drug-induced lupus in a child after treatment with zafirlukast (Accolate). J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):533-4

150 Fjellner B. Drug-induced lupus erythematosus aggravated by oral zinc therapy. Acta Derm Venereol. 1979;59(4):368-70

151 Fox RA. Disseminated lupus erythematosus - an allergic disease? Arch Pathol. 1943 Sept;36:311-5

152 Fox W. Case of lupus erythematosus. Proc R Soc Med (Dermatol Sect). 1921;14:66

153 Frank LJ. Dermatitis from Sulfanilamide. J Am Med Assoc. 1937 Sep 25;109(13):1011-2

154 Freund H. Inwiefern ist der Lupus erythematodes von allgemeinen Faktoren abhängig? Dermatol Wochenschr. 1929;2:1939

155 Frieboes W. Atlas der Haut- und Geschlechtskrankheiten. Lehrbuch. Leipzig: Vogel, 1928

156 Fries JF, Holman HR. Systemic lupus erythematosus: a clinical analysis. Philadelphia: Saunders, 1975

157 Frigui M, Kechaou M, Haddouk S, Masmoudi A, Kaddour N, Masmoudi H, Turki H, Bahloul Z. Benzylthiouracil induced ANCA-positive vasculitis: study of three cases and review of the literature. Ann Endocrinol (Paris). 2008 Dec;69(6):517-22

158 Frigui M, Masmoudi A, Kaddour N, Jlidi R, Turki H, Bahloul Z. [Neutrophilic dermatosis associated with anti-neutrophilic cytoplasmic antibodies (ANCA) after benzylthiouracil therapy.] Dermatose neutrophilique associée à des anticorps anticytoplasme des polynucléaires neutrophiles (ANCA) après prise de benzylthiouracile. Ann Dermatol Venereol. 2009 May;136(5):422-6

159 Frohne D. Heilpflanzenlexikon. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 2002

160 Fuhs. Lupus erythematosus disseminatus. Zbl Hautkrh. 1922;3(7):428-9

161 Fuhs. Lupus erythematosus subacutus mit ausgesprochener Überempfindlichkeit gegen Quarzlicht. Zbl Hautkrh. 1929;30(5-6):308-9

162 Galewsky E. Lupus erythematodes mit Verschlimmerung im Hochsommer. Zbl Hautkrh. 1923;7:159

163 Gallego H, Crutchfield CE, Lewis EJ, Gallego HJ. Report of an association between discoid lupus erythematosus and smoking. Cutis. 1999 Apr;63(4):231-4

164 Galloway. Case report. Br J Dermatol. 1896;8(3):91

165 García-Morteo O, Maldonado-Cocco JA. Lupus-like syndrome during treatment with nomifensine. Arthritis Rheum. 1983 Jul;26(7):936

166 Garovich M, Agudelo C, Pisko E. Oral contraceptives and systemic lupus erythematosus. Arthritis Rheum. 1980 Dec;23(12):1396-8

167 Gelmers HJ. Exacerbation of systemic lupus erythematodes, aseptic meningitis and acute mental symptoms, following metrizamide lumbar myelography. Neuroradiology. 1984;26(1):65-6

168 Gennerich W. Über die Ätiologie des Lupus erythematodes. Arch Dermatol Syph. 1921;135:184-207

169 Genth E. Das Pseudo-LE-Syndrom, Modell einer Arzneimittel-induzierten, systemischen Autoimmunkrankheit. Aachen: Habil.-Schr., 1987

170 Ghate JV, Turner ML, Rudek MA, Figg WD, Dahut W, Dyer V, Pluda JM, Reed E. Drug-induced lupus associated with COL-3: report of 3 cases. Arch Dermatol. 2001 Apr;137(4):471-4

171 Girard JP. Allergic reactions to antibiotics. Helv Med Acta. 1971 Dec;36(1):3-22

172 Godinho A. Drei Fälle von Sanocrysin-Exanthem bei Lupus erythematodes. Schweiz Med Wochenschr. 1927;57:37

173 Gold S. Role of sulphonamides and penicillin in the pathogenesis of systemic lupus erythematosus. Lancet. 1951 Feb 3;257(6649):268-72

174 Goldberg D, Panigrahi D, Barazi M, Abelson M, Butrus S. A case of rofecoxib-associated stevens-johnson-syndrome with corneal and conjunctival changes. Cornea. 2004 Oct;23(7):736-7

175 Goldstein N. Complications from Tattoos. J Dermatol Surg Oncol. 1979;5(11):869-78

176 Gomez-Moyano E, Vera-Casano A, Moreno-Perez D, Sanz-Trelles A, Crespo-Erchiga V. Lupus erythematosus-like lesions by voriconazole in an infant with chronic granulomatous disease. Pediatr Dermatol. 2010 Jan-Feb;27(1):105-6

177 Gono T, Matsuda M, Shimojima Y, Kaneko K, Murata H, Ikeda S. Lupus erythematosus profundus (lupus panniculitis) induced by interferon-beta in a multiple sclerosis patient. J Clin Neurosci. 2007 Oct;14(10):997-1000

178 Gougerot, Blamoutier. Poussée aigue de lupus érythémateux et d'adenite tuberculeuse par les sulfates de terres rares. Choc hémoclasique provoqué par les injections de ces préparations. Desensibilisation par injection préparante. Paris med. 1925;15:34

179 Graham Little EG. Case report. Br J Dermatol. 1902;14(12):468

180 Graham Little EG. Case report. Br J Dermatol. 1917;29(4):278-9

181 Gratwohl AA, Moutsopoulos HM, Chused TM, Akizuki M, Wolf RO, Sweet JB, Deisseroth AB. Sjögren-type syndrome after allogeneic bone-marrow transplantation. Ann Intern Med. 1977 Dec;87(6):703-6

182 Griffiths ID, Kane SP. Sulphasalazine-induced lupus syndrome in ulcerative colitis. Br Med J. 1977 Nov 5;2(6096):1188-9

183 Griffiths ID, Richardson J. Lupus-type illness associated with labetalol. Br Med J. 1979 Aug 25;2(6188):496-7

184 Grütz O. Beiträge zur Klinik und Histologie des Lupus erythematodes acutus. Arch Dermatol Syph. 1924;147(3):524-36

185 Gross R, Schölmerich P, Gerok W, eds. Die innere Medizin. Stuttgart: Schattauer, 1996

186 Grupper C. [Is lupus erythematosus a toxicoderma? (from antipyrine to hydralazine).] Le lupus érythémateux est-il une toxicoderme? (de l'antipyrine a l'hydralazine). Bull Soc Fr Dermatol Syph. 1955 May-Jun;65(3):336-8

187 Grupper C, Marcel GA. [Lupus erythematosus et neuroleptiques.] Lupus érythémateux et neuroleptiques. Bull Soc Fr Dermatol Syph. 1965 Sep-Oct;72(5):714-21

188 Grupper C, Marcel GA. Eruptions du type LE et syndromes lupiques provoquees par des medicaments. Jadassohn W, Schirren CG, eds. XIII Congressus internationalis dermatologiae, 31.7. usque ad 5.8.1967. Berlin: Springer, 1968:49-52

189 Guhl G, Diaz-Ley B, Garcia-Garcia C, Frage J, Garcia-Diez A. Chemotherapy-induced subacute lupus erythematosus. Lupus. 2009;18(9):859-60

190 Guilaine J, Boivin P, Dassonville M. Lupus érythémateux exanthématique au cours d'une pancytopenie. Rôle lupogène de la rifampicine? Bull Soc Fr Dermatol Syph. 1974;81:305

191 Guindo J, Rodriguez de la Serna A, Borja J, Oter R, Jane F, Bayes de Luna A. Propafenone and a syndrome of the lupus erythematosus type. Ann Intern Med. 1986 Apr;104(4):589

192 Gustavsen WR. [Lupus erythematosus disseminatus induced by alpha methyldopa.] Lupus erythematosus disseminatus fremkalt av alfamethyldopa. Tidsskr Nor Laegeforen. 1974 Jan 10;94(1):22-3

193 Hald A. Case of Lupus erythematosus caused by chlorprothixene (Truxal). Ugeskr Laeger. 1964 Aug 6;126:1112-4

194 Hall AF. Lupus Erythematosus in Red Part of Tatooed Area. Arch Derm Syphilol. 1943;47(4):610

195 Handley AJ. Thrombocytopenia and L. E. cells after oxyphenbutazone. Lancet. 1971 Jan 30;1(7692):245-6

196 Hardgrave KL, Neas BR, Scofield RH, Harley JB. Antibodies to vesicular stomatitis virus proteins in patients with systemic lupus erythematosus and in normal subjects. Arthritis Rheum. 1993 Jul;36(7):962-70

197 Harrison T, Sisca TS, Wood WH. Case report. Propranolol-induced lupus syndrome? Postgrad Med. 1976 Jan;59(1):241-4

198 Harron DW, Brogden RN. Acecainide (N-acetylprocainamide). A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiac arrhythmias. Drugs. 1990 May;39(5):720-40

199 Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine. 1954 Dec;33(4):291-437

200 Hausmann W, Haxthausen H. Die Lichterkrankungen der Haut. Strahlentherapie XI. Berlin: Urban und Schwarzenberg, 1929:112-3

201 Herstoff JK, Bogaars HA. Cutaneous lupus erythematosus associated with melanoma and BCG vaccine therapy. Arch Dermatol. 1979 Jul;115(7):856-9

202 Hettenkofer H-J, ed. Rheumatologie: Diagnostik-Klinik-Therapie. Stuttgart: Thieme, 2003

203 Heyman MR, Flores RH, Edelman BB, Carliner NH. Procainamide-induced lupus anticoagulant. South Med J. 1988 Jul;81(7):934-6

204 Hill VA, Hepburn NC. Sertraline associated discoid lupus erythematosus-like eruption. J R Army Med Corps. 1998 Jun;144(2):109-10

205 Hölzle E. Photodermatosen und Lichtreaktionen der Haut. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 2003

206 Hofbauer W. Lupus erythematodes cum exacerbatione acuta, exitus letalis. Dermatol Wochenschr. 1940;110(11):219-23

207 Hoffman BJ. Sensitivity to sulfadiazine resembling acute disseminated lupus erythematosus. Arch Derm Syphilol. 1945;51(3):190-2

208 Hoffmann E. Über die Bedeutung der Strahlenbehandlung in der Dermatologie nebst Bemerkungen über ihre biologische Wirkung. Strahlentherapie. 1916;7:1-32

209 Hoigné R. Arzneimittel-Allergien. Bern: Huber, 1965

210 Holmes S, Kemmet D. Exacerbation of systemic lupus erythematosus induced by terbinafine. Br J Dermatol. 1998 Dec;139(6):1133

211 Homberg JC, Abuaf N, Plouin PF, Menard J, Fillastre JP. Antinuclear antibodies and lupus induced during treatment of arterial hypertension. Role of beta-blockers and alpha-methyldopa. J Pharmacol. 1983;14 Suppl 2:61-6

212 Horn HR, Hadidian Z, Johnson JL, Vassallo HG, Williams JH, Young MD. Safety evaluation of tocainide in the American Emergency Use Program. Am Heart J. 1980 Dec;100(6 Pt 2):1037-40

213 House JK, George LW, Oslund KL, Galey FD, Stannard AW, Koch LM. Primary photosensitization related to ingestion of alfalfa silage by cattle. J Am Vet Med Assoc. 1996 Nov 1;209(9):1604-7

214 Howard EJ, Brown SM. Clofibrate-induced antinuclear factor and lupus-like syndrome. J Am Med Assoc. 1973 Dec 10;226(11):1358-9

215 Huang JY, Wu CH, Shih IH, Lai PC. Complications mimicking lupus flare-up in a uremic patient undergoing pegylated liposomal doxorubicin therapy for cervical cancer. Anticancer Drugs. 2004 Mar;15(3):239-41

216 Hutchinson J. Illustrations of clinical surgery, consisting of plates, photographs, woodcuts, diagrams, etc. London: Churchill, 1878

217 Hutchinson J. Lectures on clinical surgery. Vol I Pt I. On certain rare diseases of the skin. London: Churchill, 1878

218 Hutchinson J. A smaller atlas of illustrations of clinical surgery: consisting of one hundred and thirtysix plates with descriptive letterpress. London: West, 1895:Pl 38

219 Hutchinson J. Archives of Surgery. Vol IX. London: Churchill, 1898

220 Huwyler T, Wuthrich B, Muhlethaler K, Kuhn H, Jungbluth H, Spath P, Hochreutener H. [Angioedema caused by enalapril (Reniten).] Enalapril-(Reniten)assoziierte Angioodeme. Schweiz Med Wochenschr. 1989 Sep 16:119(37):1253-6

221 Ingels AE. Lupus erythematosus treated with sulfanilamide. Arch Derm Syphilol. 1938;37(5):879-84

222 Jadassohn J. Lupus erythematodes. Mraček F. Handbuch der Hautkrankheiten. Wien: Holder, 1904:298-424

223 Jeffrey RF. Transient lupus anticoagulant and fansidar therapy. Postgrad Med J. 1986 Sep;62(731):893-4

224 Jeffries M, Bruner G, Glenn S, Sadanandan P, Carson CW, Harley JB, Sawalha AH. Sulpha allergy in lupus patients: a clinical perspective. Lupus. 2008;17(3):202-5

225 Jesionek A. Richtlinien der modernen Lichtbehandlung. Strahlentherapie. 1916;7:41-65

226 Jessner S. Hauttuberkulose (Lupus vulgaris etc.) einschliesslich Tuberkulide und Lupus erythematodes. Würzburg: Kabitzsch, 1909

227 Johnstone EC, Whaley C. Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatment. Br Med J. 1975 Jun 28;2(5973):724-5

228 Jumez N, Dereure O, Bessis D, Guillot B. Flare of cutaneous lupus erythematosus induced by bupropion (Zyban). Dermatology. 2004;208(4):362

229 Jungers P, Dougados M, Pelissier C, Kuttenn F, Tron F, Lesavre P, Bach JF. Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum. 1982 Jun;25(6):618-23

230 Kalivas J. A guide to the problem of photosensitivity. J Am Med Assoc. 1969 Sep 15;209(11):1706-9

231 Kallenberg CG, Hoorntje SJ, Smit AJ, Weening JJ, Donker AJ, Hoedemaeker PH, The TH. Antinuclear and antinative DNA antibodies during captopril treatment. Acta Med Scand. 1982;211(4):297-300

232 Katayama I, Nishioka K. Lupus-like syndrome induced by 2-mercaptopropionylglycine. J Dermatol. 1986 Apr;13(2):151-3

233 Kauffman CL, Fredeking AE. Lupus Erythematodes, Drug-induced. emedicine. [11.1.10]

234 Keil H. Conception of lupus erythematosus and its morphologic variants; with particular reference to "systemic" lupus erythematosus. Arch Derm Syphilol. 1937 Oct;36(4):729-57

235 Kelly J. Do plastics trigger lupus? Medscape News. [17.11.11]

236 Kendall MJ, Hawkins CF. Quinidine-induced systemic lupus erythematosus. Postgrad Med J. 1970;46(542):729-31

237 Kenedy D. Lupus erythematodes, beschränkt auf behaarten Kopf. Dermatologische Zusammenkunfte in Budapest, 7. April 1925. Zbl Hautkrh. 1925;17:629

238 Kern AB, Schiff BL. Discoid lupus erythematosus following trauma. AMA Arch Derm. 1957;75(5):685-7

239 Kerr OA, Murray CS, Tidman MJ. Subacute cutaneous lupus erythematosus associated with leflunomide. Clin Exp Dermatol 2004;29(3):319-20

240 Kierland RR. Classification and cutaneous manifestations of lupus erythematosus. Proc Staff Meet Mayo Clin. 1940 Oct 23;15(43):675-7

241 Kilburn KH, Warshaw RH. Prevalence of symptoms of systemic lupus erythematosus (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water. Environ Res. 1992 Feb;57(1):1-9

242 Kilfoyle DH, Anderson NE, Wallis WE, Nicholls DW. Recurrent severe aseptic meningitis after exposure to lamotrigine in a patient with systemic lupus erythematosus. Epilepsia. 2005 Feb;46(2):327-8

243 Kilpinen O. Über einen Fall von durch Gummireizung hervorgerufenem Erythematodes. Acta Derm Venereol. 1946;26:329-38

244 King-Smith D. External irritation as a factor in the causation of lupus erythematosus discoides. Arch Derm Syphilol. 1926;14(5):547-9

245 Klein LR, Elmets CA, Callen JP. Photoexacerbation of cutaneous lupus erythematosus due to ultraviolet A emissions from a photocopier. Arthritis Rheum. 1995 Aug;38(8):1152-6

246 Kluger N, Bessis D, Guillot B. Chronic cutaneous lupus flare induced by systemic 5-fluorouracil. J Dermatolog Treat. 2006;17(1):51-3

247 Körholz D, Nürnberger W, Göbel U, Wahn V. Gold-induced systemic lupus erythematosus. Monatsschr Kinderheilkd. 1988 Sep;136(9):644-6

248 Kohrs T. Einige Fälle von Krysolganstomatitis. Dermatol Wochenschr. 1921;72:179

249 Kossard S, Doherty E, McColl I, Ryman W. Autofluorescence of clofazimine in discoid lupus erythematosus. J Am Acad Dermatol. 1987 Nov;17(5 Pt 2):867-71

250 Krischock L, Horsfield C, D'Cruz D, Rigden SP. Drug-induced lupus and antiphospholipid syndrome associated with cysteamine therapy. Nephrol Dial Transplant. 2009 Jun;24(6):1997-9

251 Kucharz EJ, Kotulska AT, Kopec MM. Raloxifen-induced exacerbation of lupus erythematosus. Eur J Intern Med. 2002 May:13(3):212

252 Kuhn A, ed. Cutaneus lupus erythematosus. Berlin: Springer, 2005

253 Ladd AT. Procainamide-induced lupus erythematosus. N Engl J Med. 1962;267(26):1357-8

254 Lahita RG. Systemic Lupus erythematosus. New York: Elsevier, 2004

255 Lateef A, Tan KB, Lau TC. Acute generalized exanthematous pustulosis and toxic epidermal necrolysis induced by hydroxychloroquine. Clin Rheumatol. 2009 Dec;28(12):1449-52

256 Laugier P, Orusco M, Chatelanat F, Humair L, Posternak F. [Disseminated lupus erythematosus, induced by estrogens. Viral inclusions revealed by renal biopsy.] Lupus érythémateux disséminé induit par oestrogènes. "Inclusion virales" décelées dans la biopsie rénale." Bull Soc Fr Dermatol Syph. 1971;78(6):623-8

257 Leder AN, Flansbaum B, Zandman-Goddard G, Asherson R, Shoenfeld Y. Antiphospholipid syndrome induced by HIV. Lupus. 2001;10(5):370-4

258 Lee SL, Zingale SB. Pathogenesis of systemic lupus erythematosus. Mills LC, Moyer JH, eds. Inflammation and Diseases of Connective Tissue. Philadelphia: Saunders, 1961:173-180

259 Lee SL, Rivero I, Siegel M. Activation of systemic lupus erythematosus by drugs. Arch Intern Med. 1966 May;117(5):620-6

260 Lee SL, Chase PH. Drug-induced systemic lupus erythematosus. A critical review. Semin Arthritis Rheum. 1975;5(1):83-103

261 Leikin JB, Paloucek FP. Poisoning and Toxicology Handbook. New York: Informa Healthcare, 2008

262 Lenzner JA. Disseminated lupus erythematosus following administration of penicillin. Bull Fillmore Hosp. 1959;6:100-3

263 Letsas KP, Alexanian IP, Pappas LK, Kounas SP, Efremidis M, Sideris A, Kardaras F. QT interval prolongation and torsade de pointes associated with indapamide. Int J Cardiol. 2006 Oct 10;112(3):373-4

264 Lewin KJB. Phenolphthalein reaction simulating disseminated (systemic) lupus erythematosus. Lancet. 1962;280 Sept 1(7253):461

265 Li EK, Cohen MG, Ho AK, Cheng AF. Salmonella bacteraemia occurring concurrently with the first presentation of systemic lupus erythematosus. Br J Rheumatol. 1993 Jan, 32(1):66-7

266 Lindqvist T. Lupus erythematosus disseminatus after administration of mesantoin; report of two cases. Acta Med Scand. 1957 Aug 13;158(2):131-8

267 Lisse JR, Lavery JP, Goeken NE. Salsalate-induced pancytopenia in a patient with systemic lupus erythematosus. Ann Allergy. 1993 Mar;70(3):206-9

268 Littlejohn GO, Urowitz MB. Cimetidine, lupus erythematosus, and granulocytopenia. Ann Intern Med. 1979 Aug;91(2):317-8

269 Livingood CS, Pillsbury DM. Sulfathiazole in Exzematous Pyoderma: Sensitization Reaction to Successive Local and Oral Therapy; Report of Twelve Cases. J Am Med Assoc. 1943 Feb 6;121:406

270 Livingston S, Villamater C, Sakata Y, Pauli LL. Use of carbamazepine in epilepsy. Results in 87 patients. J Am Med Assoc. 1967 Apr 17;200(3):204-8

271 Livingston S, Rodriguez H, Greene CA, Pauli LL. Systemic lupus erythematosus. Occurrence in association with ethosuximide therapy. J Am Med Assoc. 1968 May 20;204(8):731-2

272 LMU München, Klinik für Wiederkäuer. Photosensibilitätsreaktionen. [7.8.12]

273 Lodin A. Discoid Lupus erythematosus and trauma. Acta Derm Venereol. 1963;43:142-8

274 Lowe G, Henderson CL, Grau RH, Hansen CB, Sontheimer RD. A systematic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol. 2011 Mar;164(3):465-72

275 Lübbe J, Willa C, Elsner P. Discoid lupus erythematosus following contact with cold liquid bitumen (cutback). Derm Beruf Umwelt. 1996;44:87-9

276 Luton EF, Finchum RN. Photosensitivity reaction to chlordiazepoxide. Arch Dermatol. 1965 Apr;91(4):362-3

277 Maas D, Merz KP, Jahn J, Schubothe H. [Lupus erythematosus-like syndrome with antimitochondrial antibodies. Report on 21 cases.] Ein Lupus erythematodes ähnliches Syndrom mit antimitochondrialen Antikörpern. Bericht über 21 Fälle. Verh Dtsch Ges Innere Med., 78. Kongress. 1972:895-8

278 MacDonald WJ. Lupus erythematosus discoides in relation to trauma. Urol Cutan Rev. 1934;38:863-6

279 Machold KP, Smolen JS. Interferon-gamma induced exacerbation of systemic lupus erythematosus. J Rheumatol. 1990 Jun;17(6):831-2

280 MacKee. Discussion of Fraser. Lupus erythematosus. Arch Derm Syphilol. 1925;12(5):750

281 Mackie BS, Mackie LE. Systemic lupus erythematosus - dermatomyositis induced by sulphacetamide eye drops. Australas J Dermatol. 1979 Apr;20(1):49-50

282 MacLeod JMH. Lupus erythematosus: some observations on its etiology. Arch Derm Syphilol. 1924;9(1):1-12

283 Magro CM, Crowson AN, Dawood M, Nuovo GJ. Parvoviral infection of endothelial cells and its possible role in vasculitis and autoimmune diseases. J Rheumatol. 2002 Jun;29(6):1227-35

284 Maignen F, Castot A, Falcy M, Efthymiou ML. Drug-induced aseptic meningitis. Therapie. 1992 Sep-Oct;47(5):399-402

285 Maltz HC, Balog DL, Cheigh JS. Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine. Ann Pharmacother. 1999 Nov;33(11):1176-9

286 Manocha D, Tenorio Cdel C, Rose F. Vancomycin leading to lupus flare in an elderly lady: a case report. Cases J. 2009 Jul 23;2:6293

287 Margerie A-H. Des principales formes du lupus et de son traitement. Gaz hôp civ mil. 1850 Aug 22;23(99):393

288 Markham A, Lamb HM. Infliximab: a review of its use in the management of rheumatoid arthritis. Drugs. 2000 Jun;59(6):1341-59

289 Markman M, Lim HW, Bluestein HG. Vancomycin-induced vasculitis. South Med J. 1986 Mar;79(3):382-3

290 Markou N, Antzoulatos N, Haniotou A, Kanakaki M, Parissis J, Damianos A. A Case of Drug-Induced Pneumonitis Caused by Carvedilol. Respiration 2004;71:650-652

291 Marshall AJ, McGraw ME, Barritt DW. Positive antinuclear factor tests with prazosin. Br Med J. 1979 Jan 20;1(6157):165-6

292 Martenstein. Lupus erythematodes subacutus + tuberkulöse Halslymphdrüsenschwellungen. Behandlung mit Plasmochin. Zbl Hautkrh. 1928;27(5-6):248-9

293 Martenstein H. Die Behandlung des Lupus erythematodes mit Krysolgan. Klin Wochenschr. 1922;1:2235

294 Marzano AV, Borghi A, Mercogliano M, Facchetti M, Caputo R. Nitrendipine-induced subacute cutaneous lupus erythematosus. Eur J Dermatol. 2003 Mar-Apr;13(2):213-6

295 Massarotti G, Cassi E, Passaleva A. Lupus-like autoimmune syndrome after levodopa and benserazide. Br Med J. 1979 Sep 1;2(6189):553

296 Matsushita K, Ozaki A, Inoue H, Kaieda T, Akimoto M, Satomura A, Arima N, Hamada H, Suruga Y, Aoki N, Fujiwara H, Tei C. Stevens-Johnson syndrome induced by mizoribine in a patient with systemic lupus erythematosus. Mod Rheumatol. 2006;16(2):113-6

297 Mattern H. Liste der Medikamente die einen Schub auslösen können. Lünen: St.-Marien-Hospital, Ohne Datumsangabe

298 Mayr J. Die Nebenwirkungen der Arzneimittel auf die Haut. Jena: Fischer, 1950

299 Mayr JK. Lupus erythematodes acutus disseminatus. Zbl Hautkrh. 1924;12:233

300 Mayr M, Giannini O, Jehle AW, Sadallah S, Buess M, Mihatsch M, Trendelenburg M. Angioödem und Lupus erythematodes. Schweiz Med Forum. 2004;4:1279-81

301 Maxwell D, Szwed JJ, Wahle W, Kleit SA. Ampicillin nephropathy. J Am Med Assoc. 1974 Oct 28;230(4):586-7

302 McCarthy FP. Lupus erythematosus. Arch Derm Syphilol. 1931 June;23(6):1184

303 McCraken M, Benson EA, Hickling P. Systemic lupus erythematosus induced by aminoglutethimide. Br Med J. 1980 Nov 8;281(6250):1254

304 McCance-Katz EF. New onset Raynaud's phenomenon in a schizophrenic patient. J Clin Psychiatry. 1991 Feb;52(2):89-90

305 medicines.ie, ed. Bendroflumethiazide. [8.1.10]

306 Medizinische Medien Informations GmbH, ed. Gelbe Liste Pharmindex. [15.11.11]

307 Medscape.com, ed. Tranylcypromine Oral. [7.8.12]

308 Meier CR, Sturkenboom MC, Cohen AS, Jick H. Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. J Rheumatol. 1998 Aug;25(8):1515-9

309 Mendese G, Demierre MF. Systemic lupus erythematosus induced by cefepime. J Am Acad Dermatol. 2011 Mar;64(3):e37

310 Merck & Co., inc., ed. The Merck Veterinary Manual, Whitehouse Station, 2008. [8.2.10]

311 Merlin F, Prochilo T, Kildani B, Lombardi C, Pasolini G, Bonetti F, Beretta GD. Discoid lupus erythematosus (DLE)-like lesions induced by capecitabine. Int J Colorectal Dis. 2008 Jul;23(7):715-6

312 Metcalf RG, Kuna A, Maccarron D. Disseminated lupus erythematosus versus drug reaction: report of a case receiving chlorpromazine. J Maine Med Assoc. 1959 Jul;50(7):251-4

313 Metcalfe W, Boulton-Jones JM. Exacerbation of lupus nephritis in association with leuprorelin injection for uterine leiomyoma. Nephrol Dial Transplant. 1997 Aug;12(8):1699-700

314 Meyler L. Phagocystosis in drug allergy. Acta Med Scand. 1954;150(1):33-8

315 Miehle W, Fehr K, Schattenkirchner M, ed. Rheumatologie in Praxis und Klinik. Stuttgart: Thieme, 2000

316 Miescher P, Delacrétaz J. [L. E. phenomenon in two cases of drug hypersensitivity.] Démonstration d'un phénomène "LE" positif dans deux cas d'hypersensibilité médicamenteuse. Schweiz Med Wochenschr. 1953;83(23):536-8

317 Millns JL, McDuffie FC, Muller SA, Jordon RE. Development of photosensivitity and an SLE-like syndrome in a patient with psoriasis. Arch Dermatol. 1978 Aug;114(8):1177-81

318 Moazzam N, Malik AA, Mehdi SA, Potti A. Treatment side effects. Case 3. Fluorouracil-induced exacerbation of systemic lupus erythematosus. J Clin Oncol. 2002 Jul 1;20(13):3032-4

319 Morris M. Case report. Br J Dermatol. 1896;8(1):17-8

320 Morris M, Fox W. Case report. Br J Dermatol. 1910;22(7):234-6

321 Morrow JD, Schroeder HA, Perry HM. Studies on the control of hypertension by Hyphex: II. Toxic reactions and side effects. Circulation. 1953;8(6):829-39

322 Mortazavi M, Mansouri P.: Ant-induced alopecia: report of 2 cases and review of the literature. Dermatol Online J. 2004 Jul 15;10(1):19

323 Moshfeghi M, Mandler HD. Ciprofloxacin-induced toxic epidermal necrolysis. Ann Pharmacother. 1993 Dec;27(12):1467-9

324 Moskowitz R, Freundlich B, Petrozzi J. Lupus Erythematosus Arising in Striae Distensae. Cutis. 1983;31(5):503-5

325 Murphy M, Barnes L. Terbinafine-induced lupus erythematosus. Br J Dermatol. 1998 Apr;138(4):708-9

326 Mutoh K, Hidaka Y, Hirose Y, Kimura M. Possible induction of systemic lupus erythematosus by zonisamide. Pediatr Neurol. 2001 Oct;25(4):340-3

327 Mysler E, Paget SA, Kimberly R. Ciprofloxacin reactions mimicking lupus flares. Arthritis Rheum. 1994 Jul;37(7):1112-3

328 Nagata C, Fujita S, Iwata H, Kurosawa Y, Kobayashi K, Kobayashi M, Motegi K, Omura T, Yamamoto M, Nose T, et al. Systemic lupus erythematosus: a case-control epidemiologic study in Japan. Int J Dermatol. 1995 May;34(5):333-7

329 Nagayama J, Tsuji H, Iida T, Hirakawa H, Matsueda T, Ohki M. Effects of contamination level of dioxins and related chemicals on thyroid hormone and immune response system in patients with "Yusho". Chemosphere. 2001 May-Jun;43(4-7):1005-10

330 Nakamura H, Okada A, Kawakami A, Yamasaki S, Ida H, Motomura M, Imanishi D, Eguchi K. Isoniazid-triggered pure red cell aplasia in systemic lupus erythematosus complicated with myasthenia gravis. Rheumatol Int. 2010 Nov;30(12):1643-5

331 Naranjo P. Clinical aspects of allergy to antibiotics. Serafini U, Frankland AW, Masala C, Jamar JM, eds. New Concepts in Allergy and Clinical Immunology. Proceedings of the VII International Congress of Allergology, Florence, October 12-17, 1970. Amsterdam: Excerpta Medica, 1971:216-23

332 National Library of Medicine. ChemIDplus Advanced. [7.8.12]

333 National Library of Medicine. PubMed. [16.11.11]

334 a) Nestico PF, Morganroth J, Horowitz LN. New antiarrhythmic drugs. Drugs. 1988 Mar;35(3):286-319

334 b) Netter P, Tréchot P, Bannwarth B, Faure G, Royer RJ. [Side effects of D-penicillamine and pyritinol. Cooperative study among French hospital drug surveillance centrers.] Effets secondaires de la D-pénicillamine et du pyritinol. Etude coopérative des centres de pharmacovigilance hospitalière français. Therapie. 1985 Nov-Dec;40(6):475-9

335 Neumann C. [Induction of subacute cutaneous lupus erythematosus by psoralen UV-A therapy.] Induktion eines subakuten kutanen Lupus erythematodes durch Psoralen-UV-A-Therapie. Z Hautkr. 1987 Nov 1;62(21):1523-4, 1527-8

336 Nicolas J, Rousset J, Lavabre P. Lupus érythémateux subaigu chez une fillette issue de parents tuberculeux après vaccination par le B. C. G. Bull Soc Fr Dermatol Syph. 1937;44:179-80

337 Nicolau S, Maisler A. Das Senear-Ushersche Syndrom bei einem Fall von Lupus erythematodes, hervorgerufen durch Goldbehandlung. Zbl Hautkrh. 1939 Mar 20;61(9-10):541-2

338 Nobl. [Case report.] Fallbeispiel. Arch Dermatol Syph. 1921;133:98-9

339 Obermoser G, Bellmann R, Pfausler B, Schmutzhard E, Sepp N. Aseptic meningo-encephalitis related to dexibuprofen use in a patient with systemic lupus erythematosus: a case report with MR findings. Lupus. 2002;11(7):451-3

340 O'Donovan WJ. Case of lupus erythematosus (juvenilis). Proc R Soc Med (Dermatol Sect). 1921;14(8):73

341 Ogryzlo MA. The L. E. (lupus erythematosus) cell reaction. Can Med Assoc J. 1956 Dec 15;75(12):980-93

342 O'Leary PA. Prognosis and Treatment of Lupus Erythematosus. Proc Staff Meet Mayo Clin. 1940 Oct 23;15(43):686-8

343 Onwukwe MF. Cutaneous complications of smallpox vaccination scars. Int J Dermatol. 1973 Sept-Oct;12(5):290-4

344 Oppenheim M. Lupus erythematosus mit universeller Ausbreitung nach Mirioninjektionen. Zbl Hautkrh. 1923;6:501

345 Orfanos CE, Garbe C. Therapie der Hautkrankheiten. Berlin: Springer, 2002

346 Ormsby, Mitchell. Lupus erythematosus with an extensive eruption on the trunk. Arch Derm Syphilol. 1924 Feb;9(2):272

347 Ottaviani P, Pezzarossa G. [Acute exacerbation of chronic lupus erythematosus and immune thrombocytopenic purpura with fatal outcome.] Esacerbatione acuta di lupus eritematoso cronico con porpora trombocitopenica ad esito letale. Ital Dermat e Sif. 1950;91:220-36

348 Paladini G. Peyronie's disease and systemic lupus erythematosus syndrome associated with metoprolol administration: a case report. Int J Tissue React. 1981 Jun;3(2):95-8

349 Parks CG, Walitt BT, Pettinger M, Chen JC, de Roos AJ, Hunt J, Sarto G, Howard BV. Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the Women's Health Initiative Observational Study. Arthritis Care Res (Hoboken). 2011 Feb;63(2):184-94

350 Parodi A, Rivara G, Guarrera M. Possible naproxen-induced relapse of subacute cutaneous lupus erythematosus. J Am Med Assoc. 1992;268(1):51-52

351 Patel GK, Anstey AV. Rifampicin-induced lupus erythematosus. Clin Exp Dermatol. 2001 May;26(3):260-2

352 Pathak MA, Epstein JH. Normal and abnormal reactions of man to light. Fitzpatrick TB et al, eds. Dermatology in general medicine. New York: McGraw-Hill, 1971:977-1036

353 Paton MD, Riddel MJ, Strong JA. Aplastic anaemia following mepacrine treatment of lupus erythematosus. Lancet. 1955 Feb 5;268(6858):281-2

354 Patri P, Nigro A, Rebora A. Lupus erythematosus-like eruption from captopril. Acta Derm Venereol. 1985;65(5):447-8

355 Paul-Ehrlich-Institut (PEI). Datenbank Verdachtsfälle von Impfkomplikationen. [19.11.11]

356 Pellegrin A. [Two new cases of allergy to tartrazine.] Deux observations nouvelles d'allergies à la tartrazine. Ann Med Interne. 1979;130:211-4

357 Pereyo-Torrellas N. p-Aminobenzoic-acid-related compounds and systemic lupus. Arch Dermatol. 1978 Jul;114(7):1097

358 Permamed, ed. Fachinformation Sportusal® Emgel. [24.10.09]

359 Petera V, Hula M. Lupus erythematosus-like eruption following treatment with penicillamine in a patient with lupus diathesis. Cas Lék Česk. 1967;106:784-6

360 Peterkin GA. Uncommon Drug Rashes. Edinb Med J. 1951;58:41

361 Peterman A, Braunstein B. Cutaneous reaction to chlorambucil therapy. Arch Dermatol. 1986 Dec;122(12):1358-60

362 Petri M, Allbritton J. Antibiotic allergy in systemic lupus erythematosus: a case-control study. J Rheumatol. 1992 Feb;19(2):265-9

363 Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, Lockshin M, Merrill JT, Belmont HM, Askanase AD, McCune WJ, Hearth-Holmes M, Dooley MA, Von Feldt J, Friedman A, Tan M, Davis J, Cronin M, Diamond B, Mackay M, Sigler L, Fillius M, Rupel A, Licciardi F, Buyon JP; OC-SELENA Trial. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005 Dec 15;353(24):2550-8

364 Pham HC, Saurat JH. Inhalation route inducing subacute cutaneous lupus erythematosus with tiotropium. Arch Dermatol. 2005 Jul;141(7):911-2

365 Pham CP, de Feiter PW, van der Kuy PH, van Mook WN. Long QTc interval and torsade de pointes caused by fluconazole. Ann Pharmacother. 2006 Jul-Aug;40(7-8):1456-61

366 Pharmazie.com, ed. Oxsoralen-Kapseln, 2007. [19.12.09]

367 Physicians Desk Reference. Oradell: Medical Economics Data, 1990

368 Pimstone BL. Systemic lupus erythematosus exacerbated by oral contraceptives. S Afr J Obstet Gynecol. 1966(4):62-3

369 Pollard KM, Hultman P. Skin-lightening creams are a possible exposure risk for systemic lupus erythematosus: comment on the article bei Finckh et al. Arthritis Rheum. 2007 May;56(5):1721; author reply 1721-2

370 Popkhristov P, Kapnilov S. Streptomycin - a factor responsible for the provocation and exacerbation of lupus erythematosus (Clinical observations). Suvr Med (Sofia). 1959;10(11):81-7

371 Porter RD, Hartman CR. Arthus reactions from insulin association with lupus erythematosus cell phenomena. J Am Med Assoc. 1970 Dec 7;214(10):1884-5

372 Powell J, Grech H, Holder J. A boy with cutaneous necrosis occurring during treatment with levamisole. Clin Exp Dermatol. 2002 Jan;27(1):32-3

373 Poza-Guedes P, Gonzalez-Perez R, Canto G. Celecoxib-induced lupus-like syndrome. Rheumatology (Oxford). 2003 Jul:42(7):916-7

374 Prime J. Des accidents toxiques produits par l'éosinate de sodium. Paris, 1900

375 Przybilla B, Georgii A, Bergner T, Ring J. Demonstration of quinolone phototoxicity in vitro. Dermatologica. 1990;181(2):98-103

376 Presley AP, Kahn A, Williamson N. Antinuclear antibodies in patients on lithium carbonate. Br Med J. 1976 Jul 31;2(6030):280-1

377 Pulay E. Stoffwechselpathologie und Hautkrankheiten. XVII. Mitteilung: Stoffwechselpathologische Analyse eines Falles von Lupus erythematodes als Grundlage einer Neuorientierung der Pathologie dieses Krankheitsbildes. - Zugleich ein Beitrag zur Pathologie des Lichtes. Dermatol Wochenschr. 1921;73(47):1217-34,(48):1245-57

378 Pusey WA. Attacks of lupus erythematosus (?) following exposure to sunlight or ohter weather factors. J Cutan Dis. 1915;33(5):388

379 Questions and answers (MD, Indiana). Quinacrine-associated alopecia, lupus and photosensitivity. J Am Med Assoc. 1984;252(9):1192-3

380 a) Racouchot J, Gaillard L, Guilaine J. [Subacute lupus erythematosus and methysergide.] Lupus érythémateux subaigu et méthysergide. Bull Soc Fr Dermatol Syph. 1968;75(4):513-5

380 b) Raeder EA, Podrid PJ, Lown B. Side effects and complications of amiodarone therapy. Am Heart J. 1985 May;109(5 Pt 1):975-83

381 Raftery EB, Denman AM. Systemic lupus erythematosus syndrome induced by practolol. Br Med J. 1973 May 26;2(5864):452-5

382 Rallison ML, O'Brien J, Good RA. Severe reactions to long-acting sulfonamides. Erythema multiforme exudativum and lupus erythematosus following administration of sulfamethoxypyridazine and sulfadimethoxine. Pediatrics. 1961 Dec;28(6):908-17

383 Rami AF, Barkan D, Mevorach D, Leitersdorf E, Caraco Y. Clozapine-induced systemic lupus erythematosus. Ann Pharmacother. 2006 May;40(5):983-5

384 Rao B. Sertraline Induced Systemic Lupus Erythematosus. The Internet Journal of Internal Medicine. 2006;6(1).[24.1.10]

385 Ravogli A. Lupus erythematosus diffusus unfortunately treated with tuberculin. J Cutan Dis. 1915;33(4):266-72

386 Rea D, Bergeron A, Fieschi C, Bengoufa D, Oksenhendler E, Dombret H. Dasatinib-induced lupus. Lancet. 2008 Aug 30:372(9640):713-4

387 Record NB. Acebutolol-induced pleuropulmonary lupus syndrome. Ann Intern Med. 1981 Sep;95(3):326-7

388 Reed BR, Huff JC, Jones SK, Orton PW, Lee LA, Norris DA. Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapie. Ann Intern Med. 1985;103(1):49-51

389 Reidenberg MM, Durant PJ, Harris RA, De Boccardo G, Lahita R, Stenzel KH. Lupus erythematosus-like disease due to hydrazine. Am J Med. 1983 Aug;75(2):365-70

390 Reiter G. Tagebuch eines Schmetterlings: Systemischer Lupus Erythematodes; Hilfestellung für Patienten und Ärzte. München: Quintessenz, 1993

391 Reynolds TB, Peters RL, Yamada S. Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. N Engl J Med. 1971 Oct 7;285(15):813-20

392 Richarz U, Hübner J, Schmeel A, Bauer R. [Striated lupus erythematosus following the Blaschko lines.] Striärer Lupus erythematodes im Verlauf der Blaschko-Linien. Hautarzt. 1986 Jun;37(6):335-7

393 Richez C, Dumoulin C, Schaeverbeke T. Infliximab induced chilblain lupus in a patient with rheumatoid arthritis. J Rheumatol. 2005;32(4):760-1

394 Rider JR, Ollier WE, Lock RJ, Brookes ST, Pamphilon DH. Human cytomegalovirus infection and systemic lupus erythematosus. Clin Exp Rheumatol. 1997 Jul-Aug;15(4):405-9

395 Rivera TL, Belmont HM, Weissmann G. Systemic Lupus erythematosus in 6 Male Cocaine Users at Bellevue Hospital. J Rheumatol. 2009 Dec;36(12):2854-5

396 Rivero I, Siegel M, Lee SL. Activation of systemic lupus erythematosus by prolonged drug therapy. Arthritis Rheum. 1963;6(3):293

397 Roberts JL, Hayashi JA. Exacerbation of SLE associated with alfalfa ingestion. N Engl J Med. 1983 Jun 2;308(22):1361

398 Robey RW, Fetsch PA, Polgar O, Dean M, Bates SE. The livestock photosensitizer, phytoporphyrin (phylloerythrin), is a substrate of the ATP-binding cassette transporter ABCG2. Res Vet Sci. 2006 Dec;81(3):345-9

399 Roche & Co, Switzerland. Data on file: tenoxicam (Ro 120068) safety data. Hoffmann-La Roche, Basel, 1988

400 Rodriguez M, Paronetto F, Schaffner F, Popper H. Antimitochondrial antibodies in jaundice following drug administration. J Am Med Assoc. 1969 Apr 7;208(1):148-50

401 Roederer J, Lix A. Lupus erythemateux fixe de la totalite du visage, du cuir chevelu, des avant-bras, des mains, de la cuisse. Bull Soc Fr Dermatol Syph. 1921;3:23

402 Rönnblom LE, Alm GV, Oberg KE. Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour. J Intern Med. 1990 Mar;227(3):207-10

403 Roitt IM, Brostoff J, Male DK. Kurzes Lehrbuch der Immunologie. Stuttgart: Thieme, 1995

404 Rook A. Lupus erythematosus. Proc R Soc Med. 1951;44:878-9

405 Rosa-Re D, Garcia F, Gascon J, Angrill J, Cervera R. Quinine induced lupus-like syndrome and cardiolipin antibodies. Ann Rheum Dis. 1996 Aug;55(8):559-60

406 Rose E, Pillsbury DM. Acute disseminated lupus erythematosus - a systemic disease. Ann Intern Med. 1939 Jan;12:951-63

407 Rose E, Pillsbury DM. Lupus erythematosus (erythematodes) and ovarian function: observations on a possible relationship, with report of 6 cases. Ann Intern Med. 1944;21(6):1022-34

408 Rosin JM. Vasculitis following procaine amide therapy. Am J Med. 1967 Apr;42(6):625-9

409 Rost GA. Lupus erythematodes als allergisch-hyperergische Systemerkrankung. Arch Dermatol Syph.1947;186(3-4):259-82

410 Rote Liste® Service GmbH. Rote Liste®. [15.11.11]

411 Rothschild B. Acrylamide-induced autoimmune phenomena. Clin Rheumatol. 2010 Sept;29(9):999-1005

412 Roudier J, Delmas PD. Tertatolol-induced lupus. Arthritis Rheum. 1988 Jan;31(1):145

413 Roura M, Lopez-Gil F, Umbert P. Systemic lupus erythematosus exacerbated by piroxicam. Dermatologica. 1991;182(1):56-8

414 Rubinstein A. LE-like disease caused by nalidixic acid. N Engl J Med. 1979 Dec 6,301(23):1288

415 Ruete AE. Beiträge zur Frage der Tuberkulide und des Lupus erythematodes: Aus d. Universitätskl. f. Hautkrankh. in Bonn (Dir.: Hoffmann). Marburg: Habil.-Schr., 1916

416 Ruppert GB, Barth WF. Tolmetin-induced aseptic meningitis. J Am Med Assoc. 1981 Jan 2;245(1):67-8

417 Rutishauser W. A review of the long-term effects of prazosin and hydralazine in chronic congestive heart failure. Eur Heart J. 1983 Jan;4 Suppl A:149-52

418 Saal JG, Daniel PT, Berg PA, Waller HD. Indoprofen-induced aplastic anaemia in systemic lupus, diagnosed by lymphocyte transformation tests. Lancet. 1985 Jun 22;1(8443):1450-1

419 Sabbatini A, Bombardieri S, Migliorini P. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I. Eur J Immunol. 1993 May;23(5):1146-52

420 Saha S, Tieng A, Pepeljugoski KP, Zandamn-Goddard G, Peeva E. Prolactin, Systemic Lupus Erythematosus, and Autoreactive B Cells: Lessons Learnt from Murine Models. Clin Rev Allergy Immunol. 2011 Feb;40(1):8-15

421 Salzman C, Shader RI, DiMascio A. Collagen disease-like syndrome following admininstration of a benzodiazepine derivative. Dis Nerv Syst. 1967 Sep;28(9):614-5

422 Samimi SS, Siegried E. Stevens-Johnson syndrome developing in a girl with systemic lupus erythematosus on high-dose corticosteroid therapy. Pediatr Dermatol. 2002 Jan-Feb;19(1):52-5

423 Sanchez-Guerrero J, Liang MH, Karlson EW, et al. Postmenopausal estrogen therapy and the risk of developing systemic lupus erythematosus. Ann Intern Med 1995;122(6):430-33

424 Sanchez-Guerrero J, Uribe AG, Jimenez-Santana L, Mestanza-Peralta M, Lara-Reyes P, Seuc AH, Cravioto MD. A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med. 2005 Dec 15;353(24):2539-49

425 Sanchez-Roman J, Wichmann I, Salaberri J, Varela JM, Nunez-Roldan A. Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica. Ann Rheum Dis. 1993 Jul;52(7):534-8

426 Sandler B, Aronson P. Yohimbine-induced cutaneous drug eruption, progressive renal failure, and lupus-like syndrome. Urology. 1993 Apr;41(4):343-5

427 Sanego. Amisulprid, Glianimon, Moclobemid, Tranylcypromin. [8.1.10]

428 Sanova Pharma Gesmbh, ed. Fachinformation Bioflorin - Kapseln. Wien, 2007. [7.8.12]

429 Sarzi-Puttini P, Panni B, Cazzola M, Muzzupappa S, Turiel M. Lamotrigine-induced lupus. Lupus. 2000;9(7):555-7

430 Sarzi-Puttini P, Atzeni F, Iaccarino L, Doria A. Environment and systemic lupus erythematosus. Autoimmunity. 2005 Nov;38(7):465-72

431 Sato T, Kogawa K, Hirayama Y, Sato Y, Nobuoka A, Kuribayashi K, Iyama S, Takada K, Hagiwara S, Takahashi S, Kato J, Sakamaki S, Ishigaki S, Niitsu Y. Pure red cell aplasia induced by clomipramine hydrochloride in a patient with SLE. Rinsho Ketsueki. 2000 Aug;41(8):648-52

432 Satoh M, Reeves WH. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med. 1994 Dec 1;180(6):2341-6

433 Sato-Matsumura KC, Koizumi H, Matsumura T, Takahashi T, Adachi K, Ohkawara A. Lupus erythematosus-like syndrome induced by thiamazole and propylthiouracil. J Dermatol. 1994 Jul;21(7):501-7

434 Saunders HC. Lupus erythematosus treated with gold and sodium thiosulphate; a report of thirty-two cases. N Y State J Med. 1929;29:942-4

435 Sauvaget F, Piette JC, Herson S, De Gennes C, Duyckaerts C, Godeau P. [Fenofibrate induced polymyositis.] Polymyosite induite par le fénofibrate. Rev Med Interne. 1991 Jan-Feb;12(1):52-4

436 Savill JS, Barrie R, Ghosh S, Muhlemann M, Dawson P, Pusey CD. Fatal Stevens-Johnson syndrome following urography with iopamidol in systemic lupus erythematosus. Postgrad Med J. 1988 May;64(751):392-4

437 Schauder S. Wenn Arzneimittel und Licht unverträglich sind. Pharmazeutische Zeitung online. 2009;(19). [3.11.09]

438 Schiff BL, Kern AB. Discoid lupus erythematosus following trauma. Br J Dermatol. 1954;66(10):357-60

439 Schleicher EM. L. E. cells after oral contraceptives. Lancet. 1968 Apr 13;1(7546):821-2

440 Schmutz JL, Cuny JF, Trechot P, Weber M, Beurey J. [Drug-induced pellagroid erythema. A case of pellagroid erythema caused by isoniazide.] Les érythémes pellagroïdes médicamenteux. Ann Dermatol Venereol. 1987;114(4):569-76

441 Schneider M, ed. Lupus erythematodes. Information für Erkrankte, Angehörige und Betreuende. Darmstadt: Steinkopff, 2004

442 Schneider SW, Staender S, Schluter B, Luger TA, Bonsmann G. Infliximab-induced lupus erythematosus tumidus in a patient with rheumatoid arthritis. Arch Dermatol 2006;142(1):115-6

443 Schoenhof. Lupus erythematodes mit isomorphem Reizeffekt. Zbl Hautkrh. 1927;24:162

444 Schuh D, Lebas de Lacour JC, Carbon C, et al. Lupus induit par le carbutamide. Ann Med Interne. 1973;124:747-49

445 Schwartz M, Kormilachev M, Kushnir M, Weller B, Rochas M, Toubi E. Lupus anticoagulant and anticardiolipin antibodies in serum of patients treated with risperidone. J Clin Psychiatry. 2009 May;70(5):769-71

446 Schwarz K, Fierz U, Storck H. Erythematodes-ähnliches Arzneimittelexanthem durch Ebimar mit positiver Basalmembran-Fluoreszenz. Dermatologica. 1970;141(2):174-6

447 Semon HC. Lupus Erythematosus cured by Injections of Solganol B which resulted in Generalized Exfoliative Dermatitis from which the patient nearly died. Proc R Soc Med. 1932 Dec;26(2):124

448 Sequeira JH. Case report. Br J Dermatol. 1903;15(5):171

449 Sequeira JH, Balean H. Lupus erythematosus: a clinical study of seventy-one cased. Br J Dermatol. 1902;14(10):367-79

450 Sergent JS, Lockshin M. Azathioprine-induced meningitis in systemic lupus erythematosus. J Am Med Assoc. 1978 Aug 11;240(6):529

451 Serrano G, Aliaga A, Planells I. Photosensitivity associated with triflusal (Disgren). Photodermatol. 1987 Apr;4(2):103-5

452 Shakoor N, Michalska M, Harris CA, Block JA. Drug-induced systemic lupus erythematosus associated with etanercept therapy. Lancet. 2002 Feb 16;359(9306):579-80

453 Shapiro M, Sosis AC, Junkins-Hopkins JM, Werth VP. Lupus erythematosus induced by medications, ultraviolet radiation, and other exogenous agents: a review, with special focus on the development of subacute cutaneous lupus erythematosus in a genetically predisposed individual. Int J Dermatol. 2004;43(2):87-94

454 Sheffer AL, Rocklin RE, Goetzl EJ. Immunologic components of hypersensitivity reactions to cromolyn sodium. N Engl J Med. 1975 Dec 11;293(24):1220-4

455 Shen EN, Sung RJ, Morady F, Schwartz AB, Scheinmann MM, DiCarlo L, Shapiro W. Electrophysiologic and hemodynamic effects of intravenous propafenone in patients with recurrent ventricular tachycardia. J Am Coll Cardiol. 1984 May;3(5):1291-7

456 Sherman JD, Love DE, Harrington JF. Anemia, positive lupus and rheumatoid factors with methyldopa. A report of three cases. Arch Intern Med. 1967 Sep:120(3):321-6

457 Shimaoka Y, Hatamochi A, Hamasaki Y, Suzuki H, Ikeda H, Yamazaki S. Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical imunotherapy in a patient with alopecia areata. J Dermatol. 2008 Mar;35(3):151-3

458 Shimizu H. Shimizu's Textbook of Dermatology. Hokkaido University Press/Nakayama Shoten Publishers, 2007

459 Shimogaki Y, Kohriyama K, Tanaka M, Mochizuki H, Toyoda Y, Nakai N, Kohno A. A case of systemic lupus erythematosus which Parkinsonism was induced by tacrolimus. Nihon Rinsho Meneki Gakkai Kaishi. 2010;33(6):329-34

460 Shulman LE, McGehee A. The nature of drug-induced systemic lupus erythematosus. Arthritis Rheum. 1960;3(5):464

461 Simpson. Lupus erythematosus. Beginn von einer Rasierverletzung. Chicago Dermatological Society, März und April 1910. Arch Dermatol Syph. 1912;112(5):552

462 Simpson JR. "Collagen disease" due to carbamazepine (Tegretol). Br Med J. 1966 Dec 10;2(5527):1434

463 Sladkova V, Mares J, Lubenova B, Hlustik P, Kanovsky P. Drug-induced systemic lupus erythematosus in interferon beta-1b therapy. Neuro Endocrinol Lett. 2011;32(1):4-6

464 Sleegers MJ, Beutler JJ, Hardon WJ, Berden JH, Verhave JC, Conemans JM, Hollander DA, Dautzenberg PL, Hoogeveen EK. Reversible rapidly progressive dementia with parkinsonism induced by valproate in a patient with systemic lupus erythematosus. J Am Geriatr Soc. 2010 Apr;58(4):799-801

465 Sliesoraitis S, Khan R, Rothman J. Methotrexate-induced Hodgkin disease in a patient with systemic lupus erythematosus. J Am Osteopath Assoc. 2009 Jun;109(6):325-8

466 Slocumb CH. Rheumatic complaints during chronic hypercortisonism and syndromes during withdrawal of cortisone in rheumatic patients. Proc Staff Meet Mayo Clin. 1953 Nov 18;28(23):655-7

467 Slocumb CH, Polley HF, Ward LE, Hench PS. Diagnosis, treatment and prevention of chronic hypercortisonism in patients with rheumatoid arthritis. Ann Intern Med. 1957 Jan;46(1):86-101

468 Smith CI, Norberg R, Isenberg D, Staines NA, Gahrton G, Ringden O, Hammarstrom L. Anti-DNA antibody synthesis after bone marrow transplantation: implications for IgG subclass restrictivity and pathogenicity of autoantibodies. Bone Marrow Transplant. 1988 Nov;3(6):583-8

469 Soejima M, Sugiura T, Kawaguchi Y, Kawamoto M, Katsumata Y, Takagi K, Nakajima A, Mitamura T, Mimori A, Hara M, Kamatani N. Association of the diplotype configuration at the Nacetyltransferase 2 gene with adverse events with co-trimoxazole in Japanese patients with systemic lupus erythematosus. Arthritis Res Ther. 2007;9(2):R23

470 Sönnichsen N. Arzneimittelsensibilisierungen bei Lupus-erythematodes-Kranken. Allergie Asthma. 1967;13:215-20

471 Sönnichsen N, Nebe H. [On chloroquine hypersensitivity in lupus erythematosus.] Zur Chlorochin-Überempfindlichkeit bei Lupus erythematodes. Dermatol Wochenschr. 1965 Aug 28;151(31):1031-4

472 Sönnichsen N, Thormann T, Apostoloff G. Klinische und morphologische Besonderheiten durch gleichzeitiges Auftreten von Lupus erythematodes und Arzneimittelexanthem. Z Haut Geschlechtskr. 1966;41(6):219-25

473 Sönnichsen N, Apostoloff E. Autoimmunkrankheiten. Jena: Fischer, 1992

474 Sohl S, Renner R, Winter U, Bodendorf M, Paasch U, Simon JC, Treudler R. [Drug-induced lupus erythematosus tumidus during treatment with adalimumab.] Medikamenteninduzierter Lupus erythematodes tumidus unter Adalimumab-Therapie. Hautarzt. 2009 Oct;60(10):826-9

475 Sonneck HJ. [Erythematosus discoides chronicus with exacerbation by spirocid.] Erythematodes discoides chronicus cum exacerbatione acuta durch Spirocid. Dtsch Gesundheitsw. 1952 Feb 21;7(8):239-44

476 Sonnenblick M, Abraham AS. Ibuprofen hypersensitivity in systemic lupus erythematosus. Br Med J. 1978 Mar 11;1(6113):619-20

477 Sontheimer RD, Maddison PJ, Reichlin M, Jordon RE, Stastny P, Gilliam JN. Serologic and HLA-Associations in Subacute Cutaneous Lupus Erythematosus, a Clinical Subset of Lupus Erythematosus. Ann Intern Med. 1982;97(5):664-71

478 Sontheimer RD, Henderson CL, Grau RH. Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation. Arch Dermatol Res. 2009 Jan;301(1):65-70

479 Spencer GA. Lupus erythematosus following burns from hydrochloric acid: report of a case. AMA Arch Derm. 1951;64(2):215-7

480 Spiera RF, Berman RS, Werner AJ, Spiera H. Ticlopidine-induced lupus: a report of 4 cases. Arch Intern Med. 2002 Oct 28:162(19):2240-3

481 Spillane AP, Xia Y, Sniezek PJ. Drug-induced lupus erythematosus in a patient treated with adalumimab. J Am Acad Dermatol. 2007;56(5 Suppl):S114-6

482 Stein AA. Lupus erythematosus on sites of operative trauma. Urol Cutan Rev. 1936;40:654-6

483 Sternberg EM, Van Woert MH, Young SN, Magnussen I, Baker H, Gauthier S, Osterland CK. Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa. N Engl J Med. 1980 Oct 2;303(14):782-7

484 Stokes JH. Discussion of Madden JF. Acute disseminated lupus erythematosus. Arch Derm Syphilol. 1932;25(5):873

485 Stratigos AJ, Antoniou C, Stamathioudaki S, Avgerinou G, Tsega A, Katsambas AD. Discoid lupus erythematosus-like eruption induced by infliximab. Clin Exp Dermatol. 2004;29(2):150-3

486 Strom BL, Reidenberg MM, West S, Snyder ES, Freundlich B, Stolley PD. Shingles, allergies, family medical history, oral contraceptives, and other potential risk factors for systemic lupus erythematosus. Am J Epidemiol. 1994 Oct 1;140(7):632-42

487 Sturfelt G, Lenhoff S, Sallerfors B, Nived O, Truedsson L, Sjoholm AG. Transplantation with allogenic bone marrow from a donor with systemic lupus erythematosus (SLE): successful outcome in the recipient and induction of an SLE flare in the donor. Ann Rheum Dis. 1996 Sep;55(9):638-41

488 Sturkenboom MC, Meier CR, Jick H, Stricker BH. Minocycline and lupuslike syndrome in acne patients. Arch Intern Med. 1999 Mar 8;159(5):493-7

489 Su JA, Wu CH, Tsang HY. Olanzapine-induced agranulocytosis in systemic lupus erythematosus: a case report. Gen Hosp Psychiatry. 2007 Jan-Feb;29(1):75-7

490 Susano R, Caminal L, Ramos D, Diaz B. Amiodarone induced lupus. Ann Rheum Dis. 1999 Oct;58(10):655-6

491 Swartz C. Lupus-like reaction to phenelzine. J Am Med Assoc. 1978 Jun 23;239(25):2693
492 Swensen E, Ravasia S. Ziprasidone-induced lupus erythematosus. Can J Psychiatry. 2004 Jun;49(6):413-4

493 Tanabe M, Iwata H, Kinoshita M, Sumiya M, Saima S. Manidipine hydrochloride-induced chyloperitoneum in an patient with systemic lupus erythematosus. Clin Nephrol. 1999 Mar;51(3):195-6

494 Temesvari E, Horvath A, Kramer M, Ablonczy E, Kiraly K. Contact Isomorphic skin reactions with DNCB in SLE and DLE. Contact Dermatitis. 1979 Apr;5(2):85-9

495 ter Borg EJ, de Jong PE, Meijer S, Kallenberg CG. Renal effects of indomethacin in patients with systemic lupus erythematosus. Nephron. 1989:53(3):238-43

496 Thiers H, Colomb D, Fayolle J. Lupus érythémateux subaigu, apparu à la suite de l'emploi immodéré d'un vasoconstricteur nasal à base de naphthazoline. Bull Soc Fr Dermatol Syph. 1959;66(1):52-4

497 Thrasher JD, Madison R, Broughton A. Immunologic abnormalities in humans exposed to chlorpyrifos: preliminary observations. Arch Environ Health. 1993 Mar-Apr;48(2):89-93

498 Timani S, Mutasim DF. Cutaneous lupus erythematosus limited to the site of a laceration. J Cutan Med Surg. 2006;10(3):139-41

499 Todd PA, Brogden RN. Oxaprozin. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic effects. Drugs. 1986 Oct:32(4):291-312

500 Tolman MM. Lupus erythematosus discoides. Its present status with regard to etiology and treatment. N Engl J Med. 1938 Nov 3;219(18):688-97

501 Trautmann A. Allergiediagnose, Allergietherapie. Stuttgart: Thieme, 2006

502 Trimeche Ajmi S, Braham R, Toumi S, Chadli Chaieb M, Maaroufi A, Ach K, Chaieb L. Benzylthiouracil-induced glomerulonephritis. Case Report Med. 2009;2009:687285

503 Tsai PC, Ko YC, Huang W, Liu HS, Guo YL. Increased liver and lupus mortalities in 24-year follow-up of the Taiwanese people highly exposed to polychlorinated biphenyls and dibenzufurans. Sci Total Environ. 2007 Mar 15;374(2-3):216-22

504 Tuleja E, Bourgarit A, Abuaf N, Le Beller C, Sereni D. [Rifampin-induced severe aseptic meningitis.] Méningite aseptique sévère induite par la rifampicine. Rev Med Interne. 2010 Sept;31(9):e-1-3

505 Tunkel AR, Shuman M, Popkin M, Seth R, Hoffman B. Minoxidil-induced systemic lupus erythematosus. Arch Intern Med. 1987 Mar;147(3):599-600

506 Uddin MS, Lynfield YL, Grosberg SJ, Stiefler R. Cutaneous reaction to spironolactone resembling lupus erythematosus. Cutis. 1979 Aug;24(2):198-200

507 Ueki H. [Köbner phenomenon in lupus erythematodes.] Köbner-Phänomen bei Lupus erythematodes. Hautarzt. 1994 Mar;45(3):154-60

508 Ueki H, Omori K. Discoid lupus erythematosus developing in areas where fragments of windshield glass had become embedded in the skin. Eur J Dermatol. 2001;11(2):127-30

509 U. S. Food and Drug Administration, ed. DiurilR (Chlorothiazide) Oral Suspension, NDA 11-870/S-040, 2008

510 Uz E, Bavbek N, Turgut FH, Kanbay M, Kaya A, Akcay A. Cefuroxime-induced lupus. J Natl Med Assoc. 2007 Sep;99(9):1066-7

511 Vachtenheim J. [Provocating factors in systemic lupus erythematosus (with reference to therapeutic agents).] Provozierende Faktoren des systematischen Lupus erythematodes (mit Berücksichtigung der Heilmittel). Z Gesamte Inn Med. 1963 Sep 15;18:842-9

512 Vachtenheim J, Vykouril J. [Methylthiouracil as a provocative factor in systemic lupus erythematosus.] Methylthiouracil jako provokujici faktor systémového lupus erythematosus. Cas Lék Česk. 1963 Dec 27:102:1413-6

513 Vandersteen PR, Jordon RE. Dermatitis herpetiformis with discoid lupus erythematosus. Occurrence of sulfone-induced discoid lupus erythematosus. Arch Dermatol. 1974 Jul;110(1):95-8

514 Vargas F, Rivas C, Zoltan T, Fuentes A, Padron L, Diaz Y, Izzo C. Photodegradation and in vitro phototoxicity of aceclofenac. Pharmazie. 2007 May;62(5):337-41

515 Vassileva SG, Mateev G, Parish LC. Antimicrobial Photosensitive Reactions. Arch Intern Med. 1998;158(18):1993-2000

516 Veiel v A. Mittheilungen über die Behandlung der chronischen Hautkrankheiten in der Heilanstalt für Flechtenkranke in Cannstatt, veröffentlicht aus Anlass ihrer 25jährigen Wirksamkeit. Stuttgart: Ebner & Seubert, 1862

517 Veiel F. Lupus erythematodes (Cazenave). Jadassohn J. Handbuch der Haut- und Geschlechtskrankheiten. Berlin: Springer, 1931

518 Veiel T. Ueber Lupus erythematosus. Tübingen: Fues, 1871

519 Verdolini R, Bugatti L, Giangiacomi M, Nicolini M, Filosa G, Cerio R. Systemic lupus erythematosus induced by Epstein-Barr virus infection. Br J Dermatol. 2002 May;146(5):877-81

520 Waagstein F. Procaine-induced lupus erythematosus. Nord Med. 1970 Apr 9;83(15):468-70

521 Waldeck W, Mueller G, Wiessler M, Brom M, Toth K, Braun K. Autofluorescent proteins as photosensitizer in eukaryontes. Int J Med Sci. 2009 Dec 1;6(6):365-73

522 Wallace DJ, Hahn BH. Dubois' Lupus erythematosus. Philadelphia: Lippincott Williams & Wilkins, 2007

523 Wallhauser HF. Discussion of MacLeod JMH. Lupus erythematosus: some observations on its etiology. Arch Derm Syphilol. 1924;9(1):10

524 Walsh JR, Zimmermann HJ. The demonstration of the L. E. phenomenon in patients with penicillin hypersensivitity. Blood. 1953 Jan;8:65-71

525 Walton B, Simpson BR, Strunin L, Doniach D, Perrin J, Appleyard AJ. Unexplained hepatitis following halothane. Br Med J. 1976 May 15;1(6019):1171-6

526 Wandl UB, Nagel-Hiemke M, May D, Kreuzfelder E, Kloke O, Kranzhoff M, Seeber S, Niederle N. Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders. Clin Immunol Immunopathol. 1992 Oct;65(1):70-4

527 Wang J, Kay AB, Fletcher J, Formica MK, McAlindon TE. Is lipstick associated with the development of systemic lupus erythematosus (SLE)? Clin Rheumatol. 2008 Sep;27(9):1183-7

528 Watsky MS, Lynfield YL. Lupus erythematosus exacerbated by griseofulvin. Cutis. 1976 Feb;17(2):361-3

529 Wechsler B, Brion NO, Colau C, Ximenes H, Godeau P. [Lupus erythematosus induced by dihydralazine.] Lupus erythematosus induit par la dihydralazine. Nouv Presse Med. 1979 Nov 19;8(45):3754-5

530 Weksler BB, Lehany AM. Naproxen-induced recurrent aseptic meningitis. DICP. 1991 Nov;25(11):1183-4

531 Wendt M, Wohlrab J, Zierz S, Deschauer M. Efalizumab-induced isolated cerebral lupus-like syndrome. Neurology. 2009 Jan 6;72(1):96-7

532 Werth V. Current Treatment of Cutaneous Lupus Erythematosus. Dermatology Online Journal. 2001;7(1):2.

533 Werther J. Lupus erythematosus. Zbl Hautkrh. 1924;14:303

534 Widener HL, Littman BH. Ibuprofen-induced meningitis in systemic lupus erythematosus. J Am Med Assoc. 1978 Mar 13;239(11):1062-4

535 Williams. Paraffinoma and lupus erythematosus. Arch Derm Syphilol. 1923;8(2):299

536 Wilske KR, Shalit IE, Willkens RF, Decker JL. Findings suggestive of systemic lupus erythematosus in subjects on chronic anticonvulsant therapy. Arthritis Rheum. 1965 Apr;8:260-6

537 Wilson JD. Antinuclear antibodies and cardiovascular drugs. Drugs. 1980 Apr;19(4):292-305

538 Wing ES, Asper SP. Observations on the use of propylthiouracil in hyperthyroidism with especial reference to long-term treatment. Bull Johns Hopkins Hosp. 1952 Mar;90(3):201-27

539 Winternitz R. Lupus erythematodes disseminatus. Zbl Hautkrh. 1926;20:855

540 Winternitz R. Lupus erythematodes disseminatus nach Hohensonnenbestrahlung. Zbl Hautkrh. 1926;21:129

541 Wise F. Discussion of Fraser. Lupus erythematosus. Arch Derm Syphilol. 1925;12(5):750

542 Wise F. Lupus erythematosus disseminatus. Arch Derm Syphilol. 1932;25(5):972-3

543 With C. An eruption of lupus erythematodes on the breast and upper arm, caused by carbon light-baths in patient with lupus erythematodes in the face. Förhandl Vid Nord Dermat Förening. 1919;4:130-3

544 With C. Lupus erythematodes, im Anschluss an ein Sonnenerythem entstanden. Dermat Z. 1920;31:45

545 With C. Lupus erythematodes, mit Verschlimmerung nach partus. Dermat Z. 1921;32:252

546 Witman G, Davis R. A lupus erythematosus syndrome induced by clonidine hydrochloride. R I Med J. 1981 Mar;64(3):147-50

547 Wolfe JT, Weinberg JM, Elenitsas R, Uberti-Benz M. Cutaneous lupus erythematosus following laserinduced thermal injury. Arch Dermatol. 1997 Mar;133(3):392-3

548 Yap HK, Loke KY, Murugasu B, Lee BW. Subclinical activation of lupus nephritis by recombinant human growth hormone. Pediatr Nephrol. 1998 Feb;12(2):133-5

549 Yasue T, Nitta Y. Domperidone-induced systemic lupus-like syndrome. J Dermatol. 1986 Aug;13(4):293-6

550 Yeruham I, Avidar Y, Perl S. An apparently gluten-induced photosensitivity in horses. Vet Hum Toxicol. 1999 Dec;41(6):386-8

551 Yoshimasu T, Hiroi A, Uede K, Furukawa F. Discoid lupus erythematosus (DLE) like lesion induced by uracil-tegafur (UFT). Eur J Dermatol. 2001 Jan-Feb;11(1):54-7

552 Zamber RW, Starkebaum G, Rubin RL, Martens HF, Wener MH. Drug induced systemic lupus erythematosus due to ophthalmic timolol. J Rheumatol. 1992 Jun;19(6):977-0

553 Zeidler H, Zacher J, Hiepe FA, eds. Interdisziplinäre klinische Rheumatologie. Heidelberg: Springer, 2008

554 Zeidler H, Michel B, eds. Differenzialdiagnose rheumatischer Erkrankungen. Berlin: Springer, 2009

555 Zhang A, Elmets CA. Drug-induced Photosensitivity. emedicine. [5.2.10]

556 Zingale SB, Minzer L, Rosenberg B, Lee SL. Drug induced lupus-like syndrome. Clinical and laboratory syndrome similar to systemic lupus erythematosus following antituberculous therapy: report of a case. Arch Intern Med. 1963 Jul;112(1):63-6

557 Zuech P, Pauwels C, Duthoit C, Mery L, Somogyi A, Louboutin A, Veyssier-Belot C. Pravastatininduced dermatomyositis. Rev Med Interne. 2005 Nov;26(11):897-902

558 Zürcher K, Krebs A. Cutaneous Drug Reactions. Basel: Karger, 1992

Top


Verlag für Neue Medizin - Gervinusstr. 47 - D-64287 Darmstadt - E-Mail